Intelerad Medical Systems, a global leader in medical image management solutions, and DiA Imaging Analysis, a leading global provider of AI-based ultrasound software solutions, announced a commercial partnership to offer DiA’s LVivo Seamless AI-based cardiac ultrasound software solution as part of Intelerad’s cardiac imaging solutions IntelePACS. This collaboration is aligned with Intelerad’s expansion of its enterprise imaging offerings in the cardiology space.
With over 130 million medical images read each year by Intelerad, the company’s 2,000 global customers will now be able to obtain critical key measurement results for their echo studies. As a result, the efficiency of routine tasks will be vastly improved, as well as the effectiveness of workflow for echo reading cardiologists and other imaging specialists in the echo lab reading environment.
DiA’s LVivo Seamless AI-based software solution runs automatically ‘behind the scenes’ on echo lab servers, automatically selecting and analyzing the optimal cardiac ultrasound images and generating key clinical indications of left and right ventricle function. The results are immediately presented on the CPACS viewer as secondary-capture clips in-motion, saving time, reducing variability and optimizing echo lab workflow.
“This collaboration aligns with Intelerad’s ongoing expansion of its enterprise imaging offerings in the cardiology space and provides our customers the latest innovations in medical imaging AI,” said AJ Watson, Chief Product Officer of Intelerad.
This partnership follows Intelerad’s latest acquisitions of cardiac companies, including LUMEDX, Digisonics and HeartIT, aimed at deepening the company’s ability to provide enterprise imaging and expand its expertise in the cardiovascular space.
“We’re excited to team up with Intelerad as they expand their footprint in the cardiac imaging space,” said Hila Goldman-Aslan, CEO and co-founder of DiA. “With Intelerad’s established presence in the medical imaging field, the value of our LVivo Seamless AI-based solution will now become more accessible to a wider base of echo labs.”